Background: Leptomeningeal disease (LMD), also known as neoplastic meningitis,
leptomeningeal carcinomatosis, or carcinomatous meningitis, is a rare cancer complication …

Background/Aim: Leptomeningeal metastases (LMs) of the spine have complex
management. We reviewed the literature on spine LMs. Materials and Methods: PubMed …

Background The objective was to evaluate the risk and predictors of developing
leptomeningeal disease (LMD) in patients with brain metastases treated with 5-fraction …

Leptomeningeal carcinomatosis (LMC), also known as leptomeningeal metastasis or
leptomeningeal disease, is the metastatic spread of cancer to the pia mater, arachnoid, and …

Leptomeningeal carcinomatosis (LC) is a rare but challenging manifestation of advanced
breast cancer with a severe impact on morbidity and mortality. We performed a systematic …

Leptomeningeal disease (LMD) is a devastating category of CNS metastasis with a very
poor prognosis and limited treatment options. With maximal aggressive therapy, survival …

Introduction: The purpose of this article is to report our institution's 10-year experience on
palliative radiotherapy for the treatment of leptomeningeal carcinomatosis (LC), assessing …

Although inhibitor of apoptosis protein‑like protein‑2 (ILP‑2) is considered to be a novel
enhancer of breast cancer proliferation, its underlying mechanism of action remains …

Background/Aim: Leptomeningeal disease (LMD) is a debilitating complication of advanced
malignancies. Immune-checkpoint inhibitors (ICIs) may alter disease course. We analyzed …

Background Dosing regimens of trastuzumab administered by intracerebroventricular (icv)
route to patients with HER2-positive brain localizations remain empirical. The objectives of …